Stephen Mellett, Arrotex’s General Manager of Pharmaceuticals, said, “We are strategic in our approach to supply therapies when others can’t or won’t. We do this to enable continued, sustainable, and affordable access for Australian patients.” …
Arrotex launches new PBS-listed combination therapy as gap emerges in hypertension treatments
November 14, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
ARCS evolves into LifeSciences Australia as part of wider strategic change
June 11, 2026 - - Latest News -
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - - Latest News -
Island secures US partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech -
Cartherics secures Japanese patent to bolster cell therapy push
June 10, 2026 - - Australian Biotech -
GSK to buy Nuvalent in a major move to acquire rights to late stage lung cancer candidates
June 10, 2026 - - Latest News -
Australian company secures US fast track for CAR-T in blood cancers
June 10, 2026 - - Latest News -
Industry campaign highlights MFN risk to US jobs and the broader economy
June 10, 2026 - - Latest News